207 related articles for article (PubMed ID: 12519762)
1. Repression of farnesoid X receptor during the acute phase response.
Kim MS; Shigenaga J; Moser A; Feingold K; Grunfeld C
J Biol Chem; 2003 Mar; 278(11):8988-95. PubMed ID: 12519762
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines.
Wang Y; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2005 Nov; 46(11):2377-87. PubMed ID: 16106051
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
[TBL] [Abstract][Full Text] [Related]
4. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
5. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.
Chen W; Owsley E; Yang Y; Stroup D; Chiang JY
J Lipid Res; 2001 Sep; 42(9):1402-12. PubMed ID: 11518759
[TBL] [Abstract][Full Text] [Related]
7. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1.
Memon RA; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Biol Chem; 2001 Aug; 276(32):30118-26. PubMed ID: 11406622
[TBL] [Abstract][Full Text] [Related]
9. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy.
Sweeney TR; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1313-20. PubMed ID: 16434558
[TBL] [Abstract][Full Text] [Related]
10. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
11. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.
Prieur X; Coste H; Rodriguez JC
J Biol Chem; 2003 Jul; 278(28):25468-80. PubMed ID: 12709436
[TBL] [Abstract][Full Text] [Related]
12. The acute phase response is associated with retinoid X receptor repression in rodent liver.
Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Biol Chem; 2000 May; 275(21):16390-9. PubMed ID: 10747970
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
14. FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits.
Xu G; Li H; Pan LX; Shang Q; Honda A; Ananthanarayanan M; Erickson SK; Shneider BL; Shefer S; Bollineni J; Forman BM; Matsuzaki Y; Suchy FJ; Tint GS; Salen G
J Lipid Res; 2003 Oct; 44(10):1956-62. PubMed ID: 12897188
[TBL] [Abstract][Full Text] [Related]
15. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
[TBL] [Abstract][Full Text] [Related]
16. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
17. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene.
Owsley E; Chiang JY
Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905
[TBL] [Abstract][Full Text] [Related]
18. Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response.
Lu B; Moser AH; Shigenaga JK; Feingold KR; Grunfeld C
J Lipid Res; 2006 Oct; 47(10):2179-90. PubMed ID: 16847310
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II.
Dikopoulos N; Weidenbach H; Adler G; Schmid RM
Eur J Clin Invest; 2003 Jan; 33(1):58-64. PubMed ID: 12492453
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
